Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniela G. Grimm
Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension
Basic and Clinical Pharmacology and Toxicology
Medicine
Toxicology
Pharmacology
Related publications
The Angiotensin II AT2Receptor Is an AT1Receptor Antagonist
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure
Case Reports in Pediatrics
Olmesartan Medoxomil Combined With Hydrochlorothiazide for the Treatment of Hypertension
Vascular Health and Risk Management
Pharmacology
Cardiology
Endocrinology
Public Health
Hematology
Environmental
Cardiovascular Medicine
Medicine
Occupational Health
Metabolism
Diabetes
Angiotensin II Type 2 Receptor Gene Transfer Elicits Cardioprotective Effects in an Angiotensin II Infusion Rat Model of Hypertension
Physiological Genomics
Genetics
Physiology
Regulation of Angiotensin II Type 1 Receptor mRNA and Protein in Angiotensin II Induced Hypertension
Hypertension
Internal Medicine
Hronotherapy Aspects of Efficiency Azilsartan Medoxomil in Combination Therapy in Patients With Hypertension and Metabolic Syndrome
Kardiologiya
Cardiovascular Medicine
Cardiology
Olmesartan Medoxomil, an Angiotensin II Receptor Blocker Ameliorates Insulin Resistance and Decreases Triglyceride Production in Fructose-Fed Rats
Hypertension Research
Internal Medicine
Cardiovascular Medicine
Physiology
Cardiology
Contribution of Angiotensin Converting Enzyme Gene Polymorphism to the Action of Angiotensin II Receptor Antagonist (CS-866).
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Effects of YM358, an Angiotensin II Type 1(AT1) Receptor Antagonist, and Enalapril on Blood Pressure and Vasoconstriction in Two Renal Hypertension Models.
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
